Powering Precision Health Announces Inaugural European Summit in Amsterdam December 12-13, 2018
Powering Precision Health (PPH), the first innovation-driven summit focused on precision health, today announced much-anticipated details for its 2018 summit, which will take place in Amsterdam Dec. 12-13.
Led by life sciences executive Kevin Hrusovsky, PPH is a non-profit organization made possible through the contributions of a wide range of sponsors committed to disrupting healthcare with innovations enabling safer, less invasive and more effective personalized drugs and treatments, as well as ultra-early detection technologies to identify diseases during their earliest, most treatable stages. The summit explores technologies and advances that can be used to identify and manage environmental disease triggers, catalyzing the promise for disease prevention and furthering strategies for slowing disease progression through lifestyle modifications and other techniques. The summit attracts renowned medical leaders, innovators, investors and advocates who are focused on advancing precision health.
“This is our first PPH summit to be held in Europe and will focus primarily on disruptive digital biomarker strategies for oncology and neurodegeneration,” said Kevin Hrusovsky, PPH Founder and Chairman. “The FDA has recently issued guidance on using biomarkers as surrogate endpoints for disease progression and is proactively utilizing fast-track approval processes for innovative diagnostics that transform medicine, particularly if they focus on high-priority diseases such as cancer and neurodegeneration. Blood-based digital biomarkers are unveiling a sea of new opportunities for seeing disease earlier, long before symptoms or when imaging is unable to detect it, opening up a vast opportunity to revolutionize new strategies for drug development, patient drug response monitoring and early detection.”
A new field of “on-therapy diagnostics” is emerging as a technique to rapidly determine if patients respond to drug therapies and treatments and if not, enabling quick intervention to alternative therapies. There is a mounting body of evidence from numerous medical innovators that digital biomarkers can play a disruptive role in most of these emerging approaches. At the summit, top thought leaders in the field of neurodegeneration will review data obtained with a highly sensitive serum Neurofilament light (NfL) assay as an early indicator of neuronal damage, with particularly compelling data on Multiple Sclerosis (MS) patients. Early information will also be shared about a major ground-breaking concussion study underway including football players at 21 major U.S. universities. In addition, top oncology thought leaders will explore similar digital biomarker techniques for measuring baseline movements of cytokines in blood, as an early indicator of efficacy or toxicity response.
A special breakout session will be held on the morning of Dec. 13 for NfL specifically, given the emerging importance of this biomarker, which could be relevant as a surrogate endpoint for 15 different MS drugs totaling more than $22B in sales each year, as well as 63 MS drug trials already underway. Quanterix’ ultrasensitive serum NfL assay, currently deployed in many drug trials and undergoing a major global analytical validation study with many pharmaceutical and biotechnology companies, will be reviewed during the breakout session.
Thanks to the incredible generosity of multiple sponsors, including Novartis, Quanterix, JP Morgan, Canaccord Genuity, Cowen Group, Leerink, Mintz Levin, and Avison Young, this year’s event is completely free to all participants. However, space is limited so an invitation must be requested here by anyone interested in attending. Learn more about the Powering Precision Health movement and the 2018 summit here.
“If you’re an innovator, investor or part of a patient advocacy group who cares about these diseases, you should be at PPH 2018,” continued Hrusovsky. “In fact, if you or anyone you know has been impacted by cancer, a concussion or neurodegenerative conditions like Alzheimer’s or MS, this should be a must-attend event for you!”
Hrusovsky’s opening keynote address will be recorded and available here for listening shortly after the conclusion of the summit.
About Powering Precision Health
Powering Precision Health is the world's first independent, non-profit organization dedicated to bringing the world's leading physicians, scientists, innovators, investors and patient advocates together to unveil their latest research on new biomarkers that are revolutionizing precision health. Founded by Kevin Hrusovsky, a widely acclaimed thought leader and visionary in life sciences and personalized medicine, Powering Precision Health is a movement that represents the intersection of new technological capabilities with the latest medical research. It’s rooted in the science of precision medicine, which shows personalized treatments to be an increasingly more effective way to maximize drug efficacy and minimize toxicity. In addition to the impact environmental and lifestyle factors can have on minimizing disease triggers, precision health marks an evolution in the way we approach disease and aims to inspire a full healthcare transformation, from philosophy to approach to outcome. In an industry often plagued by skepticism and marred by false promises, PPH puts science first and brings together stakeholders that span from fundamental research to clinical practice, investors, policy makers, patient advocacy groups, and anyone who embraces the vision of Powering Precision Health. Featuring a distinguished keynote lineup of dignitaries, the summit unveils groundbreaking approaches to prevention, early diagnosis, and next-generation treatments. Powering Precision Health is supported thanks to the generous contributions of sponsors from a wide range of companies and organizations committed to advancing precision health.
Twitter (@PPHSUMMIT): https://twitter.com/PPHSUMMIT
Lindsay Poole, 617-502-4300
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
IFF Acquires The Additive Advantage; Expands Scent, Taste, and Actives Delivery Capabilities20.2.2019 00:15:00 | Tiedote
Regulatory News: International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), has expanded and strengthened its innovation capabilities for scent, taste and active ingredients through the acquisition of The Additive Advantage (TAA), a company that develops novel technologies with diverse capabilities that span applications and industries. TAA has the expertise to develop the next-generation delivery systems technology platform that will enable the printing of flavors, fragrances, cosmetic and health & nutrition actives onto a variety of consumer products. IFF Chairman & CEO Andreas Fibig said, “The acquisition of TAA helps to expand our large portfolio of offerings to customers in a truly unique way – through print technology. With the expertise that this talented group of people brings under our roof, we envision taking delivery systems to a completely new level and ultimately enriching how consumers experience our customers’ products.” “We are genuinely exci
Guidewire Software Announces Hexaware as New Consulting Alliance Partner20.2.2019 00:15:00 | Tiedote
Hexaware Technologies, a fast growing automation-led, next generation provider of IT, BPO and consulting services, and Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced that Hexaware has joined Guidewire PartnerConnect™ as a Consulting alliance member at the Select level. With over 20 years’ experience working with P&C insurers, Hexaware has developed value-add solution and technology offerings that enable insurers to rapidly adopt Guidewire InsuranceSuite™ and Guidewire Digital products, increasing speed to implementation, mitigating execution risk, and lowering costs. Hexaware has supported Guidewire customer success in APAC and EMEA and offers localized solutions for insurers in these regions. “Digital technology is disrupting the P&C insurance industry at an unprecedented rate, and insurers are leveraging market-leading platforms, such as Guidewire InsurancePlatform™, to deliver differentiated pr
Rockwell Automation and Schlumberger Enter Joint Venture Agreement to Create Sensia, the Oil and Gas Industry’s First Fully Integrated Automation Solutions Provider20.2.2019 00:05:00 | Tiedote
Rockwell Automation (NYSE: ROK), the world’s largest company dedicated to industrial automation and information, and Schlumberger (NYSE: SLB), the world's leading provider of technology for reservoir characterization, drilling, production, and processing to the oil and gas industry, announced today that they have entered into an agreement to create a new joint venture, Sensia, the first fully integrated digital oilfield automation solutions provider. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190219005851/en/ The transaction is expected to close, and the joint venture is expected to begin serving customers, in the summer of 2019, subject to regulatory approvals and other customary conditions. The Sensia joint venture will be the first fully integrated provider of measurement solutions, domain expertise, and automation to the oil and gas industry. It will offer scalable, cloud and edge-enabled process automation, includin
IDEMIA Will Present Its 2018 Annual Financial Results to Investors on February 20, 201919.2.2019 19:07:00 | Tiedote
IDEMIA, the world leader in Augmented Identity, today announced that it will present its 2018 annual financial results to investors on Wednesday February 20, 2019. Yann Delabrière (CEO), Laurent Lemaire (CFO), and Frédéric Beylier (COO) will be presenting the financial results and taking questions the same day at 4:00 pm CET (3:00 pm London Time / 10:00 am New York Time). For more information, please refer to our website: http://investors.oberthur.com About IDEMIA IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect, travel and vote), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of
Zain Group Drives Operational Efficiencies, Financial Compliance with iconectiv’s Comprehensive Fixed Asset Management Solution19.2.2019 18:00:00 | Tiedote
Zain Group, a leading mobile telecommunications provider serving more than 47.8 million customers in the Middle East and North Africa, today announced it will incorporate the iconectiv Common Language® solution to enhance capital and operational efficiencies within the company. The solution from iconectiv, an authoritative partner of the global communications industry, will help Zain gain new business insights through the comprehensive and ongoing identification and management of hundreds of thousands of network assets. With $3 billion in annual revenue and operations in more than eight countries, Zain is deploying iconectiv Common Language to ensure the flow of consistent and accurate information throughout its network. “At Zain, we are passionate about customer experience, operational effectiveness and preparing the path for continued business growth,” said Ossama Matta, CFO, Zain Group. “iconectiv Common Language will not only give us real-time status of our network assets but also
Songtradr Acquires Leading Global Music Licensing Agency, Big Sync Music19.2.2019 17:03:00 | Tiedote
Songtradr, the largest music licensing platform in the world, today announced it has acquired Big Sync Music Ltd, the world’s leading full service, creative music licensing agency. Headquartered in London, with an APAC-focused team in Singapore and a North/South America-focused team in New York, Big Sync is the largest global music buyer of its kind. Music is sourced for local, regional and worldwide advertising campaigns on behalf of well-known brands, from Dove, Knorr, Magnum and AXE to Johnnie Walker, Samsung, Amazon and Lipton. Songtradr is the only fully-automated, open music licensing marketplace in the world, with over 400,000 artists and catalogs from 190+ countries, developing real-time data intelligence, such as the utilization of streaming and social metadata to guide the licensing experience. “Big Sync’s global footprint working with major international brands combined with Songtradr’s technology and our growing community of artists, creates an unparalleled music licensing
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme